COVID-19 patients who reported smell loss as a symptom of their infection are ten times less likely to be hospitalized for coronavirus than those who do not report anosmia.
User data from a new COVID-19 symptom tracking app reveals a loss of taste and smell are the strongest predictors of a positive coronavirus diagnosis. Using the data, researchers have developed a model to identify which combination of symptoms together could best predict COVID-19 infection in individuals.
As many as one in three COVID-19 patients report smell loss as an early symptom of the infection. Researchers say the loss of smell could be used as a key clinical indicator of infection in otherwise symptom-free or pre-symptomatic carriers of coronavirus.
The olfactory epithelium may be a hub for neurogenesis.
A study in mice reveals it is possible to regenerate stem cells of the nasal tissue.
Rockefeller researchers have developed a new diagnostic test that could help with early detection of disorders associated with olfaction problems, such as Alzheimer's and Parkinson's.
Problems with olfaction associated with Alzheimer's could be a result of damage to neurotransmitter and neuromodulator neurons in the forebrain, a new study reports.
